Literature DB >> 27576187

Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration.

Jin-Man Kim1, Mi Yeong Kim1, Kyunghee Lee2, Daewon Jeong3.   

Abstract

Cell migration during specialized stages of osteoclast precursors, mononuclear preosteoclasts, and multinucleated mature osteoclasts remain uncertain. M-CSF- and osteopontin-induced osteoclastic cell migration was inhibited by function-blocking monoclonal antibodies specific to the integrin αv and β3 subunits, suggesting that integrin αvβ3 mediates migratory signaling induced by M-CSF and osteopontin. M-CSF and osteopontin stimulation was shown to regulate two branched signaling processes, PI3K/PKCα/RhoA axis and PI3K/PKCδ/Rac1 axis. Interestingly, inactivation of RhoA or Rac1 blocked preosteoclast and mature osteoclast migration but not osteoclast precursor migration in a transwell-based cell migration assay. Moreover, the inhibitory effect on preosteoclast and mature osteoclast migration induced by Rac1 inactivation was more effective than that by RhoA inactivation. Collectively, our findings suggest that osteoclast precursor migration depends on PI3K/PKCα-PKCδ signaling mediated via integrin αvβ3 bypassing RhoA and Rac1, whereas preosteoclast and mature osteoclast migration relies on PI3K/PKCα-PKCδ/RhoA-Rac1 axis signaling mediated via integrin αvβ3 with increased dependency on PKCδ/Rac1 signaling route as differentiation progresses.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  M-CSF; Osteoclastic cell migration; Osteopontin; PI3K; PKC; Small GTPase RhoA and Rac1

Mesh:

Substances:

Year:  2016        PMID: 27576187     DOI: 10.1016/j.mce.2016.08.042

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

1.  Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3.

Authors:  Jinman Kim; Yonghwan Shin; Sunyoung Lee; Miyeong Kim; Vasu Punj; Jason F Lu; Hongin Shin; Kyunghwan Kim; Tobias S Ulmer; Jungmin Koh; Daewon Jeong; Woojin An
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

2.  SPP1 promotes Schwann cell proliferation and survival through PKCα by binding with CD44 and αvβ3 after peripheral nerve injury.

Authors:  Jiang-Bo Wang; Zhan Zhang; Jian-Nan Li; Tuo Yang; Shuang Du; Rang-Juan Cao; Shu-Sen Cui
Journal:  Cell Biosci       Date:  2020-08-20       Impact factor: 7.133

3.  Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling.

Authors:  Jin-Man Kim; Kyunghee Lee; Daewon Jeong
Journal:  BMB Rep       Date:  2018-05       Impact factor: 4.778

4.  Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility.

Authors:  Su Hyun Jin; Hyunsoo Kim; Dong Ryun Gu; Keun Ha Park; Young Rae Lee; Yongwon Choi; Seoung Hoon Lee
Journal:  BMB Rep       Date:  2018-07       Impact factor: 4.778

5.  The modulation of actin dynamics via atypical Protein Kinase-C activated Cofilin regulates metastasis of colorectal cancer cells.

Authors:  S M Anisul Islam; Rekha Patel; Raja Reddy Bommareddy; Khandker Mohammad Khalid; Mildred Acevedo-Duncan
Journal:  Cell Adh Migr       Date:  2018-11-18       Impact factor: 3.405

6.  Osteopontin in Bone Metabolism and Bone Diseases.

Authors:  Jinyan Si; Chaowei Wang; Denghui Zhang; Bo Wang; Yi Zhou
Journal:  Med Sci Monit       Date:  2020-01-30

7.  PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation.

Authors:  Xiaoying Zhao; Penglei Cui; Guoli Hu; Chuandong Wang; Lei Jiang; Jingyu Zhao; Jiake Xu; Xiaoling Zhang
Journal:  J Mol Cell Biol       Date:  2020-01-22       Impact factor: 6.216

Review 8.  β2-Integrins - Regulatory and Executive Bridges in the Signaling Network Controlling Leukocyte Trafficking and Migration.

Authors:  Carla Guenther
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

9.  Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer.

Authors:  Sohail Jahid; Jose A Ortega; Linh M Vuong; Isabella Maria Acquistapace; Stephanie J Hachey; Jessica L Flesher; Maria Antonietta La Serra; Nicoletta Brindani; Giuseppina La Sala; Jacopo Manigrasso; Jose M Arencibia; Sine Mandrup Bertozzi; Maria Summa; Rosalia Bertorelli; Andrea Armirotti; Rongsheng Jin; Zheng Liu; Chi-Fen Chen; Robert Edwards; Christopher C W Hughes; Marco De Vivo; Anand K Ganesan
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

10.  Substrate stiffness regulates the differentiation profile and functions of osteoclasts via cytoskeletal arrangement.

Authors:  Qingxuan Wang; Jing Xie; Chenchen Zhou; Wenli Lai
Journal:  Cell Prolif       Date:  2021-12-24       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.